Literature DB >> 24493259

Prevention of postoperative recurrence in Crohn's disease.

Takayuki Yamamoto1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24493259     DOI： 10.1007/s40265-014-0180-1

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  13 in total

1.  The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations.

Authors:  Gert Van Assche; Axel Dignass; Walter Reinisch; C Janneke van der Woude; Andreas Sturm; Martine De Vos; Mario Guslandi; Bas Oldenburg; Iris Dotan; Philippe Marteau; Alessandro Ardizzone; Daniel C Baumgart; Geert D'Haens; Paolo Gionchetti; Francisco Portela; Boris Vucelic; Johan Söderholm; Johanna Escher; Sibylle Koletzko; Kaija-Leena Kolho; Milan Lukas; Christian Mottet; Herbert Tilg; Séverine Vermeire; Frank Carbonnel; Andrew Cole; Gottfried Novacek; Max Reinshagen; Epameinondas Tsianos; Klaus Herrlinger; Bas Oldenburg; Yoram Bouhnik; Ralf Kiesslich; Eduard Stange; Simon Travis; James Lindsay
Journal:  J Crohns Colitis       Date:  2009-12-21       Impact factor: 9.071

2.  Infliximab prevents Crohn's disease recurrence after ileal resection.

Authors:  Miguel Regueiro; Wolfgang Schraut; Leonard Baidoo; Kevin E Kip; Antonia R Sepulveda; Marilyn Pesci; Janet Harrison; Scott E Plevy
Journal:  Gastroenterology       Date:  2008-10-31       Impact factor: 22.682

3.  Predictability of the postoperative course of Crohn's disease.

Authors:  P Rutgeerts; K Geboes; G Vantrappen; J Beyls; R Kerremans; M Hiele
Journal:  Gastroenterology       Date:  1990-10       Impact factor: 22.682

4.  Scheduled infliximab monotherapy to prevent recurrence of Crohn's disease following ileocolic or ileal resection: a 3-year prospective randomized open trial.

Authors:  Koji Yoshida; Ken Fukunaga; Hiroki Ikeuchi; Koji Kamikozuru; Nobuyuki Hida; Yoshio Ohda; Yoko Yokoyama; Masaki Iimuro; Naohisa Takeda; Kyoichi Kato; Risa Kikuyama; Kazuko Nagase; Kazutoshi Hori; Shiro Nakamura; Hiroto Miwa; Takayuki Matsumoto
Journal:  Inflamm Bowel Dis       Date:  2011-11-13       Impact factor: 5.325

5.  Early diagnosis and treatment of postoperative endoscopic recurrence of Crohn's disease: partial benefit by infliximab--a pilot study.

Authors:  Dario Sorrentino; Giovanni Terrosu; Alberto Paviotti; Marco Geraci; Claudio Avellini; Giorgio Zoli; Walter Fries; Silvio Danese; Pietro Occhipinti; Tiziano Croatto; Dimitra Zarifi
Journal:  Dig Dis Sci       Date:  2012-01-18       Impact factor: 3.199

6.  The effect of smoking after surgery for Crohn's disease: a meta-analysis of observational studies.

Authors:  George E Reese; Theodore Nanidis; Catherine Borysiewicz; Takayuki Yamamoto; Timothy Orchard; Paris P Tekkis
Journal:  Int J Colorectal Dis       Date:  2008-09-02       Impact factor: 2.571

Review 7.  A meta-analysis comparing incidence of recurrence and indication for reoperation after surgery for perforating versus nonperforating Crohn's disease.

Authors:  Constantinos Simillis; Takayuki Yamamoto; George E Reese; Satoru Umegae; Koichi Matsumoto; Ara W Darzi; Paris P Tekkis
Journal:  Am J Gastroenterol       Date:  2007-09-25       Impact factor: 10.864

8.  Faecal calprotectin and lactoferrin as markers for monitoring disease activity and predicting clinical recurrence in patients with Crohn's disease after ileocolonic resection: A prospective pilot study.

Authors:  Takayuki Yamamoto; Manabu Shiraki; Takuya Bamba; Satoru Umegae; Koichi Matsumoto
Journal:  United European Gastroenterol J       Date:  2013-10       Impact factor: 4.623

9.  The impact of early endoscopic lesions on the clinical course of patients following ileocolonic resection for Crohn's disease: A 5-year prospective cohort study.

Authors:  Takayuki Yamamoto; Takuya Bamba; Satoru Umegae; Koichi Matsumoto
Journal:  United European Gastroenterol J       Date:  2013-08       Impact factor: 4.623

Review 10.  Preventing postoperative recurrence in Crohn's disease: what does the future hold?

Authors:  Lucine Vuitton; Stéphane Koch; Laurent Peyrin-Biroulet
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.